Freestone Grove Partners’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-47,386
Closed -$151K 608
2024
Q4
$151K Buy
+47,386
New +$151K ﹤0.01% 547